A preclinical study demonstrated that human CD34+ cells transduced with a dual combination anti-HIV vector, expressing CCR5 siRNA and maC46, could efficiently support long term engraftment and differentiation into multilineage hematopoietic cells in a humanized mouse model and provide resistance against both R5- and X4-tropic HIV infection [135,136]. This evidence concerns the gene CCR5 and HIV infectious disease.